Lakah Medicos Private Limited
About Lakah Medicos Private Limited
Data last updated:
Lakah Medicos Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 May 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC120586.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kshitij Verma and Shashi Kiran Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 75 Swasthya Vihar, New Delhi, Delhi, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.42 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹2.25 Lakh (net margin 65.8%) and EBITDA of ₹3.17 Lakh (EBITDA margin 92.6%). Revenue has grown at a compounded annual rate (CAGR) of 502% over three years and 9% over five years.
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lakah Medicos Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 75 Swasthya Vihar, New Delhi, Delhi, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lakah Medicos Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Lakah Medicos Private Limited
FY 2025 filings availableLakah Medicos Private Limited reported revenue of ₹3.42 Lakh (down 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 92.6% | ||||
| Net Profit Margin | 65.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lakah Medicos Private Limited, buy the company report.
Board of directors of Lakah Medicos Private Limited
Lakah Medicos has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kshitij Verma Also directs: Milkyway Biotech Private Limited | Director | 05 Sep 2003 | 23 Years 2 Months | Current |
| Shashi Kiran Verma | Director | 05 Sep 2003 | 23 Years 2 Months | Current |
Peer comparison
Lakah Medicos Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wriver Life Sciences Private Limited | ₹3.46 Lakh (FY 2025) | 987.0% | Jaipur, Rajasthan, India | |||
| Indiaid Pharma Private Limited | ₹3.45 Lakh (FY 2025) | 136.0% | Noida, Uttar Pradesh, India | |||
| Nasoterica Labs Private Limited | ₹3.44 Lakh (FY 2025) | New Delhi, Delhi, India | ||||
| Makpar Exports Private Limited | ₹3.43 Lakh (FY 2025) | 137.0% | Mandideep, Madhya Pradesh, India | |||
| Delta Enterprises Pvt Ltd | ₹3.42 Lakh (FY 2024) | -6.0% | Kolkata, West Bengal, India | |||
| Lakah Medicos Private Limitedthis company | ₹3.42 Lakh (FY 2025) | ₹2.25 Lakh | 65.8% | -10.0% | New Delhi, Delhi, India | |
| Yazur Life Sciences Private Limited | ₹3.42 Lakh (FY 2024) | 82.0% | Panchkula, Haryana, India | |||
| Sunhill Pharma Private Limited | ₹3.41 Lakh (FY 2025) | 271.0% | Delhi, India | |||
| Innova Formulations Private Limited | ₹3.41 Lakh (FY 2025) | -8.0% | New Delhi, Delhi, India | |||
| SPJ Financial Services Private Limited | ₹3.39 Lakh (FY 2019) | 195.0% | New Delhi, Delhi, India | |||
| Soniz Meditech Private Limited | ₹3.39 Lakh (FY 2024) | 1.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Lakah Medicos Private Limited, buy the company report.
Auditor
Lakah Medicos Private Limited is audited by B K KAPUR & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B K KAPUR & CO | FY 2019 | 000852C |
Shareholding
The shareholding of Lakah Medicos Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Lakah Medicos Private Limited, buy the company report.
Legal cases
Lakah Medicos Private Limited has 1 court case on record: 1 filed by Lakah Medicos. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, East, Delhi | Criminal case | Filed by the company against individuals | Disposed |
To see the full case history of Lakah Medicos Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lakah Medicos Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Lakah Medicos Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Lakah Medicos Private Limited has 3 board changes on record since 2003: 2 appointments and 1 cessation. The latest: Lakhendra Pal Singh Awana ceased to be Director on 01 Jul 2009.
Frequently asked questions
Lakah Medicos is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 May 2003 (23+ years old) and is registered under CIN U24239DL2003PTC120586.
Lakah Medicos has 2 current directors:
- Kshitij Verma - Director
- Shashi Kiran Verma - Director
The latest financial statements of Lakah Medicos on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Lakah Medicos is U24239DL2003PTC120586. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lakah Medicos has 1 court case on record: 1 filed by the company.
Lakah Medicos was incorporated on 28 May 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Lakah Medicos by revenue are Wriver Life Sciences Private Limited, Indiaid Pharma Private Limited, Nasoterica Labs Private Limited, Makpar Exports Private Limited, Delta Enterprises Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Lakhendra Pal Singh Awana ceased to be Director on 01 Jul 2009. Kshitij Verma was appointed as Director on 05 Sep 2003. Shashi Kiran Verma was appointed as Director on 05 Sep 2003.
The registered office of Lakah Medicos is at A – 75 Swasthya Vihar, New Delhi, Delhi, India.
Lakah Medicos operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Lakah Medicos is compliant as of 25 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
